Ashland Inc. (ASH) 64.55 -1.04

Ashland, Inc.
(ASH) 64.55 -1.04

Last Trade:	64.10	Day Range:	63.53 - 64.95
Trade Time:	04:02PM	52wk Range:	41.11 - 66.95
Prev. Close:	65.14	Market Cap:	5.02B
Open:	64.07	Div Yield:	1.05
Volume:	740059	PE:
EPS:	0.69

The Latest On ASH

Three Large-Cap Stocks Insiders Are Selling Like Crazy 2/10/12 12:17pm

Fast Money Picks For February 2nd 2/1/12 7:51pm

Jefferies Raises Target on Ashland to $76 1/25/12 1:07pm

Jefferies Raises PT on Ashland to $75 1/25/12 7:32am

Earnings Roundup 1/24/12 10:01am

UPDATE: Ashland FQ1 Profit Drops 38% 1/24/12 6:58am

Ashland Reports Q1 Cont Ops EPS $1.20 vs $0.99 Est; Revenues $1.9B vs $1.99B Est 1/24/12 6:41am

Ashland to Expand Polyplasdone and Polyclar Crosslinked Polyvinylpyrrolidone Production 1/9/12 9:02am

Notable Call Options Activity in Ashland 1/3/12 1:11pm

Deutsche Bank Maintains Buy on Ashland Following Industry-Wide Lowering of Oil Prices 12/14/11 11:45am

Updated Results From Cyclacel Clinical Study Highlight Safety and Efficacy of Sequential Administration of Sapacitabine and Decitabine in Elderly Patients With AML 12/12/11 1:02pm

Isis Reports Positive Phase 1 Data Demonstrating ISIS-FXIRx Reduces Factor XI Activity Without 12/12/11 11:00am

Three Large-Cap Stocks Insiders Are Selling Like Crazy 2/10/12

Fast Money Picks For February 2nd 2/1/12

Jefferies Raises Target on Ashland to $76 1/25/12

Jefferies Raises PT on Ashland to $75 1/25/12

Earnings Roundup 1/24/12

UPDATE: Ashland FQ1 Profit Drops 38% 1/24/12

Ashland Reports Q1 Cont Ops EPS $1.20 vs $0.99 Est; Revenues $1.9B vs $1.99B Est 1/24/12

Ashland to Expand Polyplasdone and Polyclar Crosslinked Polyvinylpyrrolidone Production 1/9/12

Notable Call Options Activity in Ashland 1/3/12

Deutsche Bank Maintains Buy on Ashland Following Industry-Wide Lowering of Oil Prices 12/14/11

Updated Results From Cyclacel Clinical Study Highlight Safety and Efficacy of Sequential Administration of Sapacitabine and Decitabine in Elderly Patients With AML 12/12/11

Isis Reports Positive Phase 1 Data Demonstrating ISIS-FXIRx Reduces Factor XI Activity Without 12/12/11

Three Large-Cap Stocks Insiders Are Selling Like Crazy 2/10/12

Fast Money Picks For February 2nd 2/1/12

Dow Chemical Company Earnings Preview: Analysts Expect Higher EPS, Revenue 10/24/11

Earnings Preview: E.I. du Pont de Nemours & Company's EPS, Revenue Expected to Rise 10/20/11

The Best of the Best From the Value Investing Congress 10/19/11

Alexander Roepers: Some Buyout Targets 10/17/11

Earnings Preview: Analysts Expect E.I. du Pont de Nemours & Company Revenue, Earnings to Dip from Previous Quarter 7/25/11

Earnings Preview: Dow Chemical Company Revenue Expected to Rise from Previous Quarter 7/22/11

Top 4 Mid-Cap Stocks In The Chemicals-Major Diversified Industry With The Highest EPS Estimates 6/1/11

Top 4 Mid-Cap Stocks In The Chemicals-Major Diversified Industry With The Highest Cash 5/23/11

Calls Purchased on Ashland Inc. (ASH) 3/14/11

Calls Purchased on Ashland Inc. (ASH) 2/2/11

Jefferies Raises Target on Ashland to $76 1/25/12

Jefferies Raises PT on Ashland to $75 1/25/12

Deutsche Bank Maintains Buy on Ashland Following Industry-Wide Lowering of Oil Prices 12/14/11

Jefferies Maintains Buy Rating on Incyte 12/12/11

UPDATE: JP Morgan Raises PT to $65 on Ashland 12/2/11

The Oxen Group Initiates Albermarle, Ashland, Celanese, Dow Coverage 11/30/11

Jefferies Reiterates Buy, $65 Target on Ashland 11/29/11

Jefferies Raises Ashland PT 11/16/11

Deutsche Bank Reiterates Ashland Buy, Raises PT 11/16/11

Jefferies Raises PT on Ashland to $65 11/16/11

Deutsche Bank Raises PT on Ashland to $65 11/16/11

End-of-Day Market Summary for November 10, 2011 11/10/11

Trade ASH
NOW!

Partner Headlines

Ashland Inc. (ASH) CEO James J /ky Obrien sells 37,500 Shares 2/7/12

Value Stock Picks-Feb.7, 2012 - Zacks Rank Buys 2/7/12

'Fast Money' Recap: Mining Facebook's IPO Filing 2/1/12

Zacks Releases Four Powerful ''Buy'' Stocks: Celestica, Honeywell, Lululemon and Ashland - Press Releases 2/1/12

Ashland Inc. - Value 2/1/12

Ashland Inc. Reports Operating Results (10-Q) 1/30/12

Zacks #1 Rank Additions for Monday - Tale of the Tape 1/30/12

Why Not Drill for Natural Gas? 1/27/12

Ashland 1/24/12

'Mad Money' Lightning Round: Coke's a Keeper 12/22/11

Best Stocks for 2012 Are BLK, PBCT, GM, RIMM, HESAY 12/20/11

Press Releases

Advance Auto Parts Gives Consumers the Power to Close the Loop with Valvoline NextGen™ Motor Oil 2/10/12 Newswire Story

Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results 2/9/12 Business Wire Story

Pharmacyclics Reports Fiscal 2012 Second Quarter Financial Results 2/9/12 Newswire Story

League of American Communications Professionals (LACP) Recognizes Healthyroads' Engage! Creative Group With Gold Magellan Award for Client/Member Communications 2/9/12 GlobeNewswire Story

Sangamo BioSciences Reports Fourth Quarter and Full Year 2011 Financial Results 2/8/12 Newswire Story

Share Heart-Healthy Tips With Your Valentine, Says Healthyroads, During February's American Heart Month 2/7/12 GlobeNewswire Story

Expansion of Research in Chiropractic Care is Ushering in New Era of Evidence-Based Therapies, Says American Specialty Health 2/2/12 GlobeNewswire Story

Survey Indicates Silver&Fit(R) Members Are Healthier and More Active Than National Cohort of Similar Age 2/1/12 GlobeNewswire Story

Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2012 1/30/12 Business Wire Story

Amgen to Acquire Micromet 1/27/12 Newswire Story

Critical Alerts for Texas Instruments, Hess, Lam Research, Brinker International, and Ashland Released by Seven Summits Research 1/25/12 Newswire Story

Healthyroads(R) Total Population Health Management Program for Employees Lands New Account 1/18/12 GlobeNewswire Story

Get the latest ASH stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Ashland, Inc. stock price.

Ashland, Inc. by YCharts

Ashland Inc. (ASH) 64.55 -1.04

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On ASH

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social